Article citationsMore>>

Nicholson, W., Bolen, S., Witkop, C.T., Neale, D., Wilson, L., et al. (2009) Benefits and Risks of Oral Diabetes Agents Compared with Insulin in Women with Gestational Diabetes: A Systematic Review. Obstetrics & Gynecology, 113, 193-205.
https://doi.org/10.1097/AOG.0b013e318190a459

has been cited by the following article:

• TITLE: Medical Management of Gestational Diabetes

  AUTHORS: Ayesha Anwar, Kashif Ahmad, Evdokia Karagianni, Stephen Lindow

  KEYWORDS: Gestational Diabetes, Pregnancy, Management

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.8 No.4, April 25, 2018

  ABSTRACT: Gestational diabetes (GDM) is defined as carbohydrate intolerance that begins or is first recognized during pregnancy. The prevalence of GDM is on the rise due to increasing trends of obesity in females of child bearing age as well as due to increasing maternal age. Women at higher risk should be routinely screened of the condition and offered appropriate management in order to avoid fetal and maternal complications. GDM is associated with higher incidence of maternal and fetal complications during pregnancy and labour. There is a significant relationship between GDM and prediabetic states as well as high risk of developing type 2 diabetes mellitus. The aim of management is to keep glycaemic levels within specific targets to avoid adverse outcomes. Improved health related quality of life has been linked with treatment of gestational diabetes with active lifestyle, glucose monitoring and use of insulin. Historically, non pharmacological intervention and insulin have been the main approaches in management of GDM, though recently there is an emerging evidence of use of oral hypoglycemic agents. In this article we have reviewed the existing evidence and recommendations in management of GDM.